Organon & Co
(MEX:OGN)
MXN
371
0 (0%)
Market Cap: 96.71 Bil
Enterprise Value: 247.12 Bil
PE Ratio: 4.98
PB Ratio: 108.24
GF Score: 62/100 - Q1 2024 Organon & Co Earnings Call TranscriptMay 02, 2024MXN299Earnings
- Q4 2023 Organon & Co Earnings Call TranscriptFeb 15, 2024MXN270Earnings
- Organon & Co at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Organon & Co at Piper Sandler Healthcare Conference TranscriptNov 29, 2023
- Q3 2023 Organon & Co Earnings Call TranscriptNov 02, 2023MXN281Earnings
- Q2 2023 Organon & Co Earnings Call TranscriptAug 08, 2023MXN360Earnings
- Q1 2023 Organon & Co Earnings Call TranscriptMay 04, 2023MXN425Earnings
- Q4 2022 Organon & Co Earnings Call TranscriptFeb 16, 2023MXN500 (-6.72%)Earnings
- Organon & Co at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Organon & Co at Piper Sandler Healthcare Conference TranscriptNov 29, 2022
- Q3 2022 Organon & Co Earnings Call TranscriptNov 03, 2022MXN500Earnings
- Q2 2022 Organon & Co Earnings Call TranscriptAug 04, 2022MXN647.72Earnings
- Q1 2022 Organon & Co Earnings Call TranscriptMay 05, 2022MXN663Earnings
- Organon & Co at Cowen Health Care Conference (Virtual) TranscriptMar 09, 2022
- Q4 2021 Organon & Co Earnings Call TranscriptFeb 17, 2022MXN694.06Earnings
- Organon & Co at JPMorgan Healthcare Conference TranscriptJan 10, 2022
- Organon & Co at Evercore ISI HealthCONx Virtual Conference TranscriptDec 01, 2021
- Q3 2021 Organon & Co Earnings Call TranscriptNov 11, 2021MXN670 (-11.48%)Earnings
- Organon & Co at Morgan Stanley Global Healthcare Conference (Fireside Chat) TranscriptSep 13, 2021
- Q2 2021 Organon & Co Earnings Call TranscriptAug 12, 2021MXN668 (+11.52%)Earnings
Organon & Co at Evercore ISI HealthCONx Virtual Conference Transcript
Dec 01, 2021 / 06:50PM GMT
Release Date Price:
MXN655
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Hello, everyone. Thank you for joining us. It's a pleasure to have Organon management join us for the very first time. I was actually hoping to do it on a more dedicated NDR setting and not in a broader conference, but I do think it's a great form to get this first meeting off the ground. So great to have you guys.
Kevin Ali
Organon & Co. - CEO & Director
Pleasure.
Matthew M. Walsh
Organon & Co. - CFO
Thank you.
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Excellent. Before we begin, I thought it might be helpful just to turn it over to you, Kevin and Matt, to kick it off and maybe lay out your priorities and what's on top of your mind?
Kevin Ali
Organon & Co. - CEO & Director
Yes. Thanks, Umer. Listen, I mean
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)